BioSpace News Archive

Prices of medical care are too often unknown until the patient receives the bill after the fact, so the Association of American Physicians and Surgeons thanks the Trump Administration for rules issued last week to help shine some sunlight on the secret prices that hospitals and health plans try to keep hidden from patients.

The INRC has tripled in size over the past year and now has more than 75 organizations, spanning leading universities around the world, government labs, neuromorphic startup companies, and now several Fortune Global 500 members.

A stunning revelation came back in April, when an Oxford published study pointed to only 3% of the cancer drugs tested between 2000 and 2015 were approved to treat patients, whereas another study released this September posited the reason for this level of failure laying with scientists incorrectly targeting.

Pulse Biosciences, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 11,000 shares of Pulse Biosciences common stock to two recently hired non-executive employees on November 15, 2019 and 207,684 shares of Pulse Biosciences common stock to Sandra Gardiner, Chief Financial Officer and Executive Vice President of Finance and Administration, on November 18, 2019.

Pomerantz LLP announces that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. and certain of its officers.

The Image Gently® and Image Wisely® awareness campaigns, radiology and industry collaboration to advance low-dose technologies, growing use of the ACR Dose Index Registry, and mandatory accreditation of imaging facilities under Medicare are among the primary factors that produced a 15-20 percent reduction in medical radiation dose that Americans receive.

Novartis has announced that the U.S. Food and Drug Administration approved its new drug to treat sickle cell disease.

Centerline Biomedical, Inc., a spinout company from Cleveland Clinic, announced the successful first human clinical use of its groundbreaking IOPS™ technology.

Hope Orthopedics of Oregon announced the addition of fellowship-trained orthopedic surgeon, Dr. Shane Hess to their Salem, Oregon clinic, located at 1600 State Street.

An unexpected brain region is important for Dravet Syndrome, finds study.